“Regulatory flexibility must be tailored for cell and gene therapies,” said FDA Commissioner Marty Makary, M.D., M.P.H. “These are common-sense reforms that will address the unique characteristics of ...
Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...
Akadeum Life Sciences, the leader in buoyant microbubble cell separation, today announced that its Chief Executive Officer ...
Shortly after securing a partnership with Sanofi, InduPro is linking up with Eli Lilly in efforts to discover new cancer ...
As the premier wellness clinic in Dubai, AEON Clinic is bridging the gap between traditional aesthetics and advanced ...
GC Therapeutics, Inc. (GCTx), a biotechnology company created to scale and unlock the next generation of cell therapy-based medicines through its TFome™ cellular programming platform, today announced ...
Enrollment on track in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis IND application for Descartes-08 in myositis accepted by FDA; ...
An overview of how specialty laboratories use integrated scientific approaches to deliver high-quality infectious disease ...
Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Ticker symbol: ALOPM), a biopharmaceutical company specializing in precision medicine for the treatment of resistant and ...
Sourced from the rugged coastline of Brittany, France, the Eryngium maritimum - known as the "King of Stress Resistance" - ...
Endophytic fungus from from Madagascar periwinkle offers a greener, cheaper way to produce the cancer drug vinblastine.
Nearly 1 in 7 adults in the United States lives with chronic kidney disease, a condition that often advances quietly until ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback